Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Beta-Adrenergic blockers
1 evidence topic · 1 source
Ulixacaltamide
Essential tremor
- Manufacturer
- Praxis Precision Medicines
- Regulatory submission
- NDA submitted by February 2026
- Launch
- Not announced
- Last updated